mPEG

Highly purified, polyethylene glycol (PEG) Pharmicell has the technology to manufacture high-quality mPEG derivatives, and we maintain various cooperative relationships from R&D to commercialization by working closely with domestic and foreign pharmaceutical companies. Recently, the importance of PEG as a major component of lipid nanoparticles (LNP), which is an efficient delivery system for gene therapy products and vaccines, is increasing. We have a patented technology for purification that removes by-products in the manufacture of mPEG derivatives, and mPEG used for medicine is characterized by high purity with a PDI value of 1.03 or less and a diol PEG content of 0.5% or less. In addition, based on our technology, we can manufacture and supply mPEG products for pharmaceutical use in which the molecular weight and functional groups desired by customers are introduced in ton units. In addition, based on our technology, we can manufacture and supply mPEG products with the molecular weight and functional groups desired by the customer, in metric ton unit. Recently, we have developed, manufactured and supplied mPEG derivatives used in LNP (Lipid Nano Particle), as a delivery system for mRNA vaccines.